Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 3
1985 5
1986 29
1987 33
1988 31
1989 63
1990 56
1991 62
1992 60
1993 64
1994 66
1995 63
1996 43
1997 50
1998 52
1999 43
2000 43
2001 38
2002 37
2003 45
2004 30
2005 36
2006 43
2007 51
2008 39
2009 39
2010 45
2011 51
2012 48
2013 88
2014 98
2015 82
2016 57
2017 72
2018 93
2019 72
2020 118
2021 133
2022 150
2023 143
2024 45

Text availability

Article attribute

Article type

Publication date

Search Results

2,270 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Kuehn R, Stoesser N, Eyre D, Darton TC, Basnyat B, Parry CM. Kuehn R, et al. Cochrane Database Syst Rev. 2022 Nov 24;11(11):CD010452. doi: 10.1002/14651858.CD010452.pub2. Cochrane Database Syst Rev. 2022. PMID: 36420914 Free PMC article. Review.
Time to defervescence in participants treated with cefixime may be longer compared to participants treated with fluoroquinolones (mean difference (MD) 1.74 days, 95% CI 0.50 to 2.98, 3 trials, 425 participants; low-certainty evidence). ...Trials suggest that there may be n …
Time to defervescence in participants treated with cefixime may be longer compared to participants treated with fluoroquinolones (mea …
Clinical Efficacy of Cefixime for the Treatment of Early Syphilis.
Stafylis C, Keith K, Mehta S, Tellalian D, Burian P, Millner C, Klausner JD. Stafylis C, et al. Clin Infect Dis. 2021 Sep 7;73(5):907-910. doi: 10.1093/cid/ciab187. Clin Infect Dis. 2021. PMID: 33640982 Free PMC article. Clinical Trial.
This randomized, 2-arm, noncomparative pilot study evaluated the efficacy of oral cefixime 400 mg in achieving a 4-fold rapid plasma reagin titer decrease by 3 or 6 months after treatment. The proportion of cefixime arm participants treated successfully was 87% (95% …
This randomized, 2-arm, noncomparative pilot study evaluated the efficacy of oral cefixime 400 mg in achieving a 4-fold rapid plasma …
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.
Młynarczyk-Bonikowska B, Majewska A, Malejczyk M, Młynarczyk G, Majewski S. Młynarczyk-Bonikowska B, et al. Med Microbiol Immunol. 2020 Apr;209(2):95-108. doi: 10.1007/s00430-019-00651-4. Epub 2019 Dec 4. Med Microbiol Immunol. 2020. PMID: 31802195 Free PMC article. Review.
Currently, the global problem is the emergence and a threat of spread of N. gonorrhoeae strains resistant to extended-spectrum cephalosporins (ESC), such as injectable ceftriaxone and oral-used cefixime. Especially, dangerous are multi-resistant strains resistant simultane …
Currently, the global problem is the emergence and a threat of spread of N. gonorrhoeae strains resistant to extended-spectrum cephalosporin …
Resistance-Guided Therapy for Neisseria gonorrhoeae.
Allan-Blitz LT, Adamson PC, Klausner JD. Allan-Blitz LT, et al. Clin Infect Dis. 2022 Oct 29;75(9):1655-1660. doi: 10.1093/cid/ciac371. Clin Infect Dis. 2022. PMID: 35818315 Free PMC article.
Resistance to ciprofloxacin is determined by the presence of a single mutation at codon 91 of the gyrase A gene; molecular assays to guide therapy are commercially available. Resistance to cefixime is conferred via 1 of 6 critical mutations in either the mosaic penA gene o …
Resistance to ciprofloxacin is determined by the presence of a single mutation at codon 91 of the gyrase A gene; molecular assays to guide t …
Clinical pharmacokinetics of cefixime: a systematic review.
Ajmal M, Zamir A, Rehman AU, Imran I, Saeed H, Majeed A, Aziz M, Alqahtani F, Rasool MF. Ajmal M, et al. Xenobiotica. 2023 Mar;53(3):149-162. doi: 10.1080/00498254.2023.2217265. Epub 2023 Jun 1. Xenobiotica. 2023. PMID: 37216497 Review.
Cefixime is an antibiotic from the cephalosporin class used to treat various bacterial infections. ...A dose-dependent increase in AUC and C(max) of cefixime was depicted in healthy volunteers. The clearance of cefixime decreased according to the degree of re …
Cefixime is an antibiotic from the cephalosporin class used to treat various bacterial infections. ...A dose-dependent increase in AU …
Antibiotics for treating gonorrhoea in pregnancy.
Comunián-Carrasco G, Peña-Martí GE, Martí-Carvajal AJ. Comunián-Carrasco G, et al. Cochrane Database Syst Rev. 2018 Feb 21;2(2):CD011167. doi: 10.1002/14651858.CD011167.pub2. Cochrane Database Syst Rev. 2018. PMID: 29465747 Free PMC article. Review.
We considered both trials to be at a high risk of bias.One trial compared ceftriaxone (125 mg, intramuscular) with cefixime (400 mg, oral); the other trial had three arms, and assessed ceftriaxone (250 mg, intramuscular) versus either amoxicillin (3 g, oral) plus probeneci …
We considered both trials to be at a high risk of bias.One trial compared ceftriaxone (125 mg, intramuscular) with cefixime (400 mg, …
[Whipple's disease].
Puéchal X. Puéchal X. Rev Med Interne. 2009 Mar;30(3):233-41. doi: 10.1016/j.revmed.2008.06.020. Epub 2008 Aug 22. Rev Med Interne. 2009. PMID: 18722696 Review. French.
Efficacy and safety of ceftriaxone for uncomplicated gonorrhoea: a meta-analysis of randomized controlled trials.
Bai ZG, Bao XJ, Cheng WD, Yang KH, Li YP. Bai ZG, et al. Int J STD AIDS. 2012 Feb;23(2):126-32. doi: 10.1258/ijsa.2009.009198. Int J STD AIDS. 2012. PMID: 22422688 Review.
Cure rates of ceftriaxone 250 mg were significantly better than cefixime 400 mg (OR 1.77; 95% CI 1.11-2.80) as was ceftriaxone 125 mg versus spectinomycin 2 g (OR 3.44; 95% CI 1.08-10.90). There was no statistically significant difference between ceftriaxone 250 mg and …
Cure rates of ceftriaxone 250 mg were significantly better than cefixime 400 mg (OR 1.77; 95% CI 1.11-2.80) as was ceftriaxone 125 mg …
Clavulanate combinations with mecillinam, cefixime or cefpodoxime against ESBL-producing Enterobacterales frequently associated with blaOXA-1 in a paediatric population with febrile urinary tract infections.
Birgy A, Madhi F, Jung C, Levy C, Cointe A, Bidet P, Hobson CA, Bechet S, Sobral E, Vuthien H, Ferroni A, Aberrane S, Cuzon G, Beraud L, Gajdos V, Launay E, Pinquier D, Haas H, Desmarest M, Dommergues MA, Cohen R, Bonacorsi S; Group of the National Observatory of Urinary tract Infection due to ESBL-producing Enterobacteriaceae in children. Birgy A, et al. J Antimicrob Chemother. 2021 Oct 11;76(11):2839-2846. doi: 10.1093/jac/dkab289. J Antimicrob Chemother. 2021. PMID: 34453533
We studied the impact of beta-lactamases and Enterobacterales' genotypes on the cefixime, cefpodoxime and mecillinam amoxicillin/clavulanate MICs. ...We focused especially on the isolates' ST and their type of beta-lactamases. Clinical outcomes of patients who received …
We studied the impact of beta-lactamases and Enterobacterales' genotypes on the cefixime, cefpodoxime and mecillinam amoxicillin/clav …
2,270 results